MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Stock Quote
- LAURUS LABS
LAURUS LABS Share Price (LAUL)
Here is the latest stock price and chart of Laurus Labs . For more details, see the Laurus Labs company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report. Since small-cap stocks interest you, here's a proven approach on investing in small-cap stocks.
LIVE NOW: Join Our Urgent Broadcast on India's Revival with Tanushree Banerjee
| Live BSE Quotes | Sep 24, 2021 (Close) | ||
|---|---|---|---|
| Price (Rs)609.80 | Open (Rs) 625.00 | High (Rs) 626.95 | Low (Rs) 608.00 |
| % Change-1.95 | Volume 73,650 | Value (Rs) 45,217,051 | 52-Week H/L 723.55 / 249.29 |
| Live NSE Quotes | Sep 24, 2021 (Close) | ||
|---|---|---|---|
| Price (Rs)610.15 | Open (Rs) 625.30 | High (Rs) 626.90 | Low (Rs) 608.10 |
| % Change-1.93 | Volume 2,093,230 | Value (Rs) 1,285,455,334 | 52-Week H/L 723.75 / 251.28 |
| Change | |||||
|---|---|---|---|---|---|
| 1 Day -1.95% | 1 Month -9.14% | 3 Months -2.53% | 1 Year 136.11% | ||
| Valuation | ||||
|---|---|---|---|---|
| EPS (Rs)* 19.64 | P/E Ratio (x) 31.06 | Market Cap (Rs m) 327,220.14 | P/BV (x) 12.62 | Dividend Yield (%) 0.33 |
| *Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
- Charts
-
S&P BSE SENSEX 
PERIOD - Advanced Charts new
- Charts by TradingView
LAURUS LABS Share Price Today:
LAURUS LABS last traded price was down 2.0% to Rs 609.8 on the BSE. On the NSE, LAURUS LABS last traded price was down 1.9% to Rs 610.2. The total volume of shares traded was 2.2 m.
Overall, the broader S&P BSE HEALTHCARE Index was down by 1.4%. And the benchmark S&P BSE SENSEX was at 60,048.5 (up 0.3%).
Over the last 30 days, the LAURUS LABS share price is down 4.2%. And over the last one year, LAURUS LABS share price is up 123.2%.
The current market capitalisation of LAURUS LABS stands at Rs 327,220.14 m. For more information, check out the list of top 100 companies in India in terms of market cap.
As of June 2021, company promoters held 27.30% stake in LAURUS LABS , with no shares having been pledged. To know more, check out the latest shareholding pattern of LAURUS LABS .
What else is happening in the markets today? Dig in...
- TRACK NOW:
- Most Active Stocks Rs 0 to 10
- Most Active Stocks Rs 10 to 20
- Top Gainers Today BSE A Group
- Top Gainers Today NSE Above Rs 20
- Top Gainers Today BSE Above Rs 20
- Top Gainers Today BSE Sensex
- Top Gainers Today BSE Small Cap
- Top Gainers Today BSE 500
- Top Losers Today BSE A Group
- Most Active Stocks Rs 1 to 2
- Top Losers Today NSE Above Rs 20
- Buzzing Stocks Today
- Most Popular Stocks BSE 30
- TRENDING ON EQUITYMASTER:
- Warren Buffett - The Value Investor
- Your Ultimate Guide to Penny Stock Investing
- How to Invest in Gold
- Basics of Value Investing
- Benjamin Graham
- The Best Bluechip Stocks to Buy
- How to Invest in Silver
- The Best Small-cap Stocks to Buy
- 10 Rules for Successful Long-Term Investing
- How to Invest in the Share Market
- Best Stocks to Buy Today
- How to Use P/E for Successful Investing
- How to Find Undervalued Stocks
- Differences Between Trading and Investing
- SWOT Analysis for Stocks
- The Best Dividend Stocks to Buy
Today's Market
Sensex Ends Above 60,000-Mark, Nifty Tops 17,850; Asian Paints & Eicher Motors Climb 3%(Closing)
Indian share markets witnessed volatile trading activity throughout the day today and ended higher.
Related Views On News
LAURUS LABS Announces Quarterly Results (1QFY22); Net Profit Up 40.7% (Quarterly Result Update)
Jul 31, 2021 | Updated on Jul 31, 2021For the quarter ended June 2021, LAURUS LABS has posted a net profit of Rs 2 bn (up 40.7% YoY). Sales on the other hand came in at Rs 13 bn (up 31.2% YoY). Read on for a complete analysis of LAURUS LABS 's quarterly results.
Laurus Labs Hits New Life High. Up 500%+ in One Year (Views On News)
Jun 8, 2021Laurus Labs trades higher for the eight straight day, soars 73% in 3 months.
5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)
Sep 3, 2021These companies are likely to benefit the most from Covid-19 vaccines.
Apollo Hospitals' Shares Rally Over 5%, Hit Record-High on Strong Results (Views On News)
Aug 16, 2021The company reported a 73% YoY increase in revenue driven by an uptick in the hospital and pharmacy business.
J B Chemicals & Pharma's Decent Performance Puts Stock in Focus (Views On News)
Aug 13, 2021The company seeks to expand the market for prescription lozenges with new launches this year.
More Views on NewsMost Popular
5 Specialty Chemical Stocks that Turned Multibaggers in One Year (Views On News)
Sep 17, 2021These specialty chemical stocks have surged 200% or more in the last year. Do you own any?
A Rare Buying Opportunity in an Exciting Stock (Profit Hunter)
Sep 16, 2021Whether agriculture sector goes through a structural transformation or not, this agrochemical stock has a good chance of winning.
5 Indian Companies with Over 7% in Dividend Yield (Views On News)
Sep 17, 2021These stocks will give you better yields than bank deposits.
A Great Time to Buy ITC (Profit Hunter)
Sep 17, 2021Is the worst over for the stock of ITC?
India's Most Trusted Corporate Group is... (Views On News)
Sep 11, 2021We conducted a poll of 17 of the most popular corporate groups in India. With an overwhelming response from 5,274 participants, here is what we found.
MoreOUR TOP 5 IDEAS
- Free Report: Multibagger Stock Ideas 2021
- Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
- Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
- Free Report: How to Profit from Sensex 100,000
- No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.
TRACK LAURUS LABS
- Track your investment in LAURUS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
- Add To MyStocks
MORE ON LAURUS LABS
LAURUS LABS 8-QTR ANALYSIS
COMPARE LAURUS LABS WITH
MARKET STATS
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
FOLLOW
APP
EQUITYMASTER SUPPORTS
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.